NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME-ASSOCIATED CORONAVIRUS - Patent 1855719

(19)

(11)

EP 1 855 719 A2

(12)

(43)	Date of publication:
	21.11.2007 Bulletin 2007/47

(21)	Application number: 06720569.0

(22)	Date of filing: 08.02.2006

(51)

International Patent Classification (IPC):

A61K 39/215^(2006.01)

C12Q 1/70^(2006.01)

(86)	International application number:
	PCT/US2006/004599

(87)	International publication number:
	WO 2006/086561 (17.08.2006 Gazette 2006/33)

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	AL BA HR MK YU

(30)

Priority:

08.02.2005 US 651046 P
31.05.2005 US 141925

(71)	Applicant: THE NEW YORK BLOOD CENTER
	New York, NY 10021 (US)

(72)	Inventors:
	JIANG, Shibo Fresh Meadows, NY 11365 (US) HE, Yuxian Bronx, NY 10463 (US)

(74)	Representative: Capasso, Olga
	de Simone & Partners Via Vincenzo Bellini, 20 00198 Roma 00198 Roma (IT)

(54)	NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME-ASSOCIATED CORONAVIRUS